Study of dupilumab administration for refractory adulthood asthma
Not Applicable
- Conditions
- bronchial asthma
- Registration Number
- JPRN-UMIN000038873
- Lead Sponsor
- Sagamihara National Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. The sensitivity to multiple drugs 2. Women who is pregnancy or breast feeding 3. Patients who joins other clinical trial study 4. Patients judged unsuitable as subjects by doctor's judgment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in symptom score occured 1 to 4 months after administration of dupilumab
- Secondary Outcome Measures
Name Time Method Change in lung function test Change in inflammatory markers